Latest News

EC amends marketing authorisation for Pharming’s Ruconest to include self-administration

EC amends marketing authorisation for Pharming’s Ruconest to include self-administration

SMC rejects two indications of myeloma drugs Kyprolis and Darzalex in Scotland

Drug approval body the Scottish Medicines Consortium (SMC) has rejected two life-prolonging indications of new myeloma drugs, Kyprolis (carfilzomib) and Darzalex (daratumumab), for use in the...

SMC rejects two indications of myeloma drugs Kyprolis and Darzalex in Scotland

US FDA accepts Mylan’s BLA for proposed trastuzumab product

Biocon and Mylan have announced acceptance of the latter’s biologics licence application (BLA) by the US Food and Drug Administration (FDA) for MYL-1401O, a proposed biosimilar trastuzumab....

US FDA accepts Mylan’s BLA for proposed trastuzumab product

US FDA grants fast track designation for Starpharma’s VivaGel treatment

US FDA grants fast track designation for Starpharma’s VivaGel treatment

Orthocell collaborates with J&J’s DePuy Synthes for Ortho-ATI approach

Regenerative medicine company Orthocell has announced plans to collaborate with DePuy Synthes Products, part of the Johnson & Johnson (J&J) family of companies, for its Ortho-ATI stem-cell...

Orthocell collaborates with J&J’s DePuy Synthes for Ortho-ATI approach

UK scientists discover new chemical inhibitor of cancer stress signal

Scientists from the Institute of Cancer Research (ICR), London, have discovered a new chemical inhibitor that blocks a crucial system used by cancer cells to cope with...

UK scientists discover new chemical inhibitor of cancer stress signal

Pitt and Bayer to advance research for heart, lung and blood disease indications

Pitt and Bayer to advance research for heart, lung and blood disease indications

New study finds antidepressant use increases hip fracture risk in people with Alzheimer’s disease

A new study from the University of Eastern Finland has found that the use of antidepressants nearly doubles the risk of hip fracture among community-dwelling people with Alzheimer’s disease....

New study finds antidepressant use increases hip fracture risk in people with Alzheimer’s disease

Valeant to sell Dendreon to China’s Sanpower for $819.9m

Valeant to sell Dendreon to China’s Sanpower for $819.9m

EC ratifies positive opinion for PTC’s Translarna marketing authorisation renewal

The European Commission (EC) has ratified a positive opinion for the annual renewal of PTC Therapeutics’ Translarna (ataluren) marketing authorisation for the treatment of nonsense...

EC ratifies positive opinion for PTC’s Translarna marketing authorisation renewal

Ipsen to acquire global oncology assets from Merrimack for $1.25bn

Ipsen to acquire global oncology assets from Merrimack for $1.25bn

US FDA accepts Roche’s supplemental biologics licence application

The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics Licence Application (sBLA) and granted priority review for Tecentriq (atezolizumab) to treat people...

US FDA accepts Roche’s supplemental biologics licence application

Japan’s Takeda to acquire US cancer drug manufacturer ARIAD for $5.2bn

Japanese-based Takeda Pharmaceutical Company has signed an agreement to acquire American oncology company ARIAD Pharmaceuticals for approximately $5.2bn....

Japan’s Takeda to acquire US cancer drug manufacturer ARIAD for $5.2bn

Merus and IRB to develop novel agents to target tumour microenvironment

Netherlands-based immuno-oncology company Merus and the Institute for Research in Biomedicine (IRB) Barcelona have collaborated to jointly develop novel agents that target the tumour...

Merus and IRB to develop novel agents to target tumour microenvironment

AbCellera to discover antibodies against membrane protein targets using mAb platform

AbCellera to discover antibodies against membrane protein targets using mAb platform

Aurobindo Pharma to acquire Generis for €135m

Indian company Aurobindo Pharma has signed an agreement through its wholly owned subsidiary Agile Pharma to acquire Portugal-based Generis Farmacêutica from Magnum Capital Partners for €135m....

Aurobindo Pharma to acquire Generis for €135m

New trial successfully blocks EPO signalling to improve cord-blood transplant process

A scientist at the University of Rochester Medical Center, US, has discovered the importance of a hormone called erythropoietin (EPO) for umbilical cord blood transplants as therapy for...

New trial successfully blocks EPO signalling to improve cord-blood transplant process

Prokarium and Probiomed to manufacture orally administered vaccines for diarrhoea

Prokarium and Probiomed to manufacture orally administered vaccines for diarrhoea

Synpromics and GE Healthcare to develop synthetic promoters

UK-based synthetic promoter and gene control company Synpromics and GE Healthcare are set to collaborate to develop customised synthetic...

Synpromics and GE Healthcare to develop synthetic promoters

RedHill and Concordia sign co-promotion agreement for Donnatal drug promotion

Israeli-based RedHill Biopharma has signed a co-promotion agreement with Canadian-based Concordia International’s subsidiary to acquire certain US promotion rights for the prescription oral...

RedHill and Concordia sign co-promotion agreement for Donnatal drug promotion

Eisai’s Fycompa licensed for treatment of partial-onset seizures

Japanese-based Eisai has announced the licensing of Fycompa (perampanel) for adjunctive treatment of partial-onset seizures in Jordan, Saudi Arabia and the United Arab Emirates...

Eisai’s Fycompa licensed for treatment of partial-onset seizures
cachename:Newscachekey:rd-137342983_-779801984_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_541212976